Evidence map›Paper›PMID 25356338›Full record

ArticleNew microbes and new infections2014

A severe case of persistent diarrhoea associated with Arcobacter cryaerophilus but attributed to Campylobacter sp. and a review of the clinical incidence of Arcobacter spp.

M J Figueras, A Levican, I Pujol, F Ballester, M J Rabada Quilez, F Gomez-Bertomeu

Open access · goldAbstract read
In one paragraph

Article in New microbes and new infections, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Occurrence, Sources and Virulence Potential ofEnvironmental science & technology · 2024
    Article
  7. Antibiotics (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
  10. Widespread Multidrug Resistance ofAntibiotics (Basel, Switzerland) · 2023
    Article
  11. Article
  12. First case ofIDCases · 2023
    Article
  13. The Prevalence ofMicroorganisms · 2022
    Review
  14. Article
  15. Article
  16. RND Efflux Systems Contribute to Resistance and Virulence ofAntibiotics (Basel, Switzerland) · 2021
    Article
  17. Occurrence and characterization ofItalian journal of food safety · 2021
    Article
  18. Occurrence and Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2021
    Article
  19. Search forApplied and environmental microbiology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

M J FiguerasUnitat de Microbiologia, Departament de Cièancies Mediques Básiques, Facultad de Medicina i Ciencias de la Salud, IISPV, Universidad Rovira i Virgili Sant Lorenzo 21, 43201, Reus, Spain.
A LevicanUnitat de Microbiologia, Departament de Cièancies Mediques Básiques, Facultad de Medicina i Ciencias de la Salud, IISPV, Universidad Rovira i Virgili Sant Lorenzo 21, 43201, Reus, Spain ; Laboratorio de Patología de Organismos Acuáticos y Biotecnolog\xEDa Acuícola, Facultad de Ciencias Biológicasl, Facultad de Ciencias Biológicas, Universidad Andrés Bello Viña del Mar, Chile.
I PujolUnitat de Microbiologia, Departament de Cièancies Mediques Básiques, Facultad de Medicina i Ciencias de la Salud, IISPV, Universidad Rovira i Virgili Sant Lorenzo 21, 43201, Reus, Spain ; Servei de Microbiologia, Hospital Universitari Sant Joan de Reus Reus, Spain, Tarragona, Spain.
F BallesterUnitat de Microbiologia, Departament de Cièancies Mediques Básiques, Facultad de Medicina i Ciencias de la Salud, IISPV, Universidad Rovira i Virgili Sant Lorenzo 21, 43201, Reus, Spain ; Servei de Microbiologia, Hospital Universitari Sant Joan de Reus Reus, Spain, Tarragona, Spain.
M J Rabada QuilezABS de La Selva del Camp Tarragona, Spain.
F Gomez-BertomeuServei de Microbiologia, Hospital Universitari Joan XXII Tarragona, Spain.
Universidad Rovira i Virgili · ESHospital Universitari Joan XXIII de Tarragona · ESInstitut d'Investigació Sanitària Pere Virgili · ESObservatori de l'Ebre · ESUniversidad Andrés Bello · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although rarely, Arcobacter spp. have been associated with diarrhoea and bacteraemia. We report a persistent case in a healthy 26-year-old Spanish male of bloody diarrhoea, which was attributed to Campylobacter but in fact was caused by Arcobacter cryaerophilus, as determined by sequencing of the rpoB gene. The isolate was re-identified by matrix-assisted laser desorption ionization time of flight (MALDI-TOF) and genotyped for five putative virulence genes and for seven genes included in the Arcobacter multilocus sequence typing database. The low score obtained by MALDI-TOF indicates the need to complement the database with more isolates. Only the ciaB gene, which encodes for an invasin, was detected. Despite the isolate belonging to a new sequence type, three of the alleles (glnA, pgm and tkt) had been found previously in isolates from faeces of patients with diarrhoea. This study, together with the reviewed literature, indicates that Arcobacter can produce bacteraemia and that the isolation from patients with diarrhoea range from 0.11% to 1.25%. This study also demonstrates that Arcobacter species are confused with Campylobacter spp., as previously suggested. This is one of the factors that leads to underestimation of their incidence together with the use of inappropriate detection and identification methods.

Indexed as

Arcobacteremerging or re-emerging diseasesgastrointestinal diseasepersistent diarrhoea

Identifiers

PMID25356338
PMCPMC4184587
OpenAlexW1992827037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.